iShares Core Growth Allocation ETF vs McKesson Corporation — how do they compare? iShares Core Growth Allocation ETF trades at $69.87, while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation pays a 0.42% dividend while iShares Core Growth Allocation ETF pays none, and iShares Core Growth Allocation ETF is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.
| AOR | MCK | |
|---|---|---|
52-Week High | $70.12 | $995.69 |
52-Week Low | $62.26 | $659.01 |
Market Cap | — | $105.14B |
Sector | — | Health |
Enterprise Value | — | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.
Read more on AOR →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →